Dr. Daniel Kiboi


Prof. Faith Osier Dr. Gordon Awandare

Daniel studied Biochemistry & Molecular Biology at JKUAT, Kenya. His postgraduate research focused on selecting and identifying molecular markers associated with antimalarial drugs piperaquine and lumefantrine resistance in rodent malaria parasites Plasmodium berghei. His study mapped promising mutations in proteins that are highly plausible candidates for mediators of drug action/resistance. During his PhD training, he visited Drs Oliver and Julian lab at the Wellcome Trust Sanger Institute. He trained on transfection work using gene knockout and epitope tagging, PlasmoGEM vectors for P. berghei and their application in validating resistance markers/drug transporters/targets. He later established and continued with the P. berghei transfection in KEMRI, Nairobi. Daniel joined the KEMRI-WTRP, Kilifi in 2016 as PostDoc under the WACCBIP Programme. His expanded focus is validating Plasmodium proteins associated not only with drug resistance but also to genes of interest in malaria immunity using both PlasmoGEM resources and CRISPR/Cas9 system.